Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 26, 2007

View Archived Issues

Studies of dapagliflozin, sergliflozin presented at EASD

Phase I/II studies assess ABT-751 combination therapy in non-small cell lung cancer

CADI-05 enhances chemotherapy for non-small cell lung cancer

Preclinical antitumor activity of the HDAC inhibitor panobinostat

Collaboration between SMA Foundation and BG Medicine / News in Context

CHMP recommends approval of Tasigna in CML patients nonresponsive to Glivec

NIDDK plans study of diabetes vaccine Diamyd for type 1 diabetes

FDA approves Novo Nordisk's Norditropin for children with Turner syndrome

Roche places hold on development of MAXY-alpha for hepatitis C and B

Exelixis and Bristol-Myers extend collaboration agreement for therapies targeting LXR

Patient enrollment for NeurogesX's confirmatory phase III trial of NGX-4010 completed

Efficacy of RAM-150 against multidrug-resistant pathogens

Pan-PPAR agonist PPM-204 lowers glucose and insulin in patients with type 2 diabetes

Novozymes reports on new defensin-type plectasin derivatives with in vivo antibacterial efficacy

CHMP issues positive opinion for Pegintron and Rebetol for retreating hepatitis C

Abbott and Eisai file for approval of second indication of adalimumab in Japan

Odanacatib increases bone mineral density in postmenopausal women

Preclinical models, phase I study detail activity of ACE-011

Eucreas recommended for E.U. approval in type 2 diabetes

Onconase enhances radiation responses in models of lung cancer

Adnexus Therapeutics to be acquired by Bristol-Myers Squibb

CHMP grants positive opinion to Vectibix MAA for metastatic colorectal cancer

Metabolex initiates phase II trial of MBX-8025 alone and with Lipitor

New therapeutic agents for heart failure disclosed in recent Cytokinetics patent

Novel agents for treating irritable bowel syndrome disclosed in recent Astellas patents

Novel treatment option for obesity and related disorders reported in recent Glenmark patent

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.